(Q45141205)

English

Translating the basic and clinical cognitive neuroscience of schizophrenia to drug development and clinical trials of antipsychotic medications

scientific article published in February 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Translating the basic and clinical cognitive neuroscience of schizophrenia to drug development and clinical trials of antipsychotic medications (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

0 references

cognitive neuroscience

1 reference

based on heuristic

inferred from title

Michael Foster Green

1

object named as

Green MF

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

author name string

Braff DL

2

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

language of work or name

0 references

publication date

1 February 2001

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Biological Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

49

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

374-384

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Span of apprehension performance, neuropsychological functioning, and indices of psychosis-proneness.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Sensorimotor gating and habituation evoked by electro-cutaneous stimulation in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Impaired speed of information processing in nonmedicated schizotypal patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Connecting the "dots" of brain dysfunction in schizophrenia: what does the picture look like?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Gating and habituation of the startle reflex in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Effect of antipsychotic medication on speed of information processing in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Prestimulus effects on human startle reflex in normals and schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Neuroanatomy of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Strong inference, theory testing, and the neuroanatomy of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

The continuous performance test, identical pairs version: II. Contrasting attentional profiles in schizophrenic and depressed patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Construct validity in psychological tests

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Effects of D2 dopamine receptor antagonists on Fos protein expression in the striatal complex and entorhinal cortex of the nonhuman primate

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Postmortem studies of the hippocampal formation in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Continuous performance tests in schizophrenic patients: stimulus and medication effects on performance.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

A PET study of word finding

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Functional and anatomical aspects of prefrontal pathology in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

The basal ganglia and cognitive pattern generators

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

What are the functional consequences of neurocognitive deficits in schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Does risperidone improve verbal working memory in treatment-resistant schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Startle gating deficits occur across prepulse intensities in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

The NIMH perspective: next steps in schizophrenia research

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Cortical development and thalamic pathology in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Preliminary evidence of an association between sensorimotor gating and distractibility in psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Risperidone versus haloperidol for perception of emotion in treatment-resistant schizophrenia: preliminary findings

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Eye tracking, attention, and schizotypal symptoms in nonpsychotic relatives of patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Risperidone vs. haloperidol on reaction time, manual dexterity, and motor learning in treatment-resistant schizophrenia patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Risperidone versus haloperidol on secondary memory: can newer medications aid learning?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Dopaminergic stimulation disrupts sensorimotor gating in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

The longitudinal relationship of clinical symptoms, cognitive functioning, and adaptive life in geriatric schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

On familial factors in the attentional deficit in schizophrenia: a review and report of two new subject samples

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Developmental Processes in Schizophrenic Disorders: longitudinal studies of vulnerability and stress

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

The nonlinear, complex sequential organization of behavior in schizophrenic patients: neurocognitive strategies and clinical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Information-processing deficits and thought disorder in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Working memory in schizophrenia: transient "online" storage versus executive functioning.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Thought disorder and psychosocial functioning in schizophrenia: the concurrent and predictive relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Effects of olanzapine on regional C-Fos expression in rat forebrain.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Sustained attention in children at risk for schizophrenia: findings with two visual continuous performance tests in a new sample

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

An abbreviation of the wais for clinical use

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Relationships between medication treatments and neuropsychological test performance in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

GABAergic projection from nucleus accumbens to ventral pallidum mediates dopamine-induced sensorimotor gating deficits of acoustic startle in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

The neural substrates of sensorimotor gating of the startle reflex: a review of recent findings and their implications

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

The functional significance of symptomatology and cognitive function in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Implications of normal brain development for the pathogenesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

Residual performance deficit in clinically remitted schizophrenics: a marker of schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

based on heuristic

inferred from DOI database lookup

An attentional assessment of foster children at risk for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Global attentional deviance as a marker of risk for schizophrenia: specificity and predictive validity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Familial prevalence and coaggregation of schizotypy indicators: a multitrait family study

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Schizotypy and sustained attention

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Signal detection in vigilance tasks and behavioral attributes among offspring of schizophrenic mothers and among hyperactive children.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901027-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-3223(00)01027-1

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45141205&oldid=2066969517"